Zinzino Reports 21% Revenue Growth to €255.9 Million for January–September

Group revenue climbs past a quarter of a billion euros

Zinzino AB [ZZ B], a direct selling company headquartered in Gothenburg, Sweden, reported group revenue of €255.9 million (SEK 2,787.1 million) for the first nine months of 2026. In the comparable period of 2025, the figure stood at €211.4 million (SEK 2,302.2 million).

The year-on-year increase amounts to roughly €44.5 million (SEK 484.9 million), equivalent to growth of 21 percent.

Currency conversion was carried out using the arithmetic average of the European Central Bank's monthly reference rates for January to September 2026, at an exchange rate of EUR 1 = SEK 10.8923.

Central Europe largest region, North America fastest-growing major market

Central Europe accounted for 30 percent of total group revenue, making it the company's largest region by turnover.

The regional breakdown for January–September 2026, in millions of euros with the year-on-year change in brackets, reads as follows: Central Europe 77.7 (+29%), North America 54.8 (+60%), Southern and Western Europe 41.4 (+13%), Eastern Europe 22.3 (-12%), Asia-Pacific 21.8 (+11%), Northern Europe 21.5 (0%), the Baltic states 7.5 (-5%), South America 3.0 (+300%) and Africa 1.7 (+18%).

In percentage terms, South America recorded the sharpest increase from a small base, while North America combined scale with a 60 percent advance. Eastern Europe and the Baltic states were the two regions to post declines, at -12 percent and -5 percent respectively, and Northern Europe was flat.

Sales markets and Faun Pharma

Revenue from Zinzino's pure sales markets totalled €251.7 million, an increase of 21 percent.

External revenue at subsidiary Faun Pharma came to approximately €4.2 million (SEK 45.9 million), up 14 percent, representing close to 2 percent of total group revenue.

Taken together, the sales markets and Faun Pharma produced total group revenue of €255.9 million, corresponding to the reported 21 percent growth rate.